Parámetros hematológicos de pacientes con fibrosis 2133quística de la costa caribe colombiana: análisis y asociación con aislamiento de pseudomonas aeruginosa

Parámetros hematológicos de pacientes con fibrosis 2133quística de la costa caribe colombiana: análisis y asociación con aislamiento de pseudomonas aeruginosa

Published 2009-06-30

Open | Download
PDF (Spanish) FLIP HTML (Spanish)
Issue
Vol. 7 No. 11 (2009)
Section
Artículo Original
How to Cite
Parámetros hematológicos de pacientes con fibrosis 2133quística de la costa caribe colombiana: análisis y asociación con aislamiento de pseudomonas aeruginosa. (2009). NOVA, 7(11). https://doi.org/10.22490/24629448.1083
doi

https://doi.org/10.22490/24629448.1083
Dimensions
PlumX
license

Licencia Creative Commons

NOVA by http://www.unicolmayor.edu.co/publicaciones/index.php/nova is distributed under a license creative commons non comertial-atribution-withoutderive 4.0 international.

Furthermore, the authors keep their property intellectual rights over the articles.

 

Zoraya Rodríguez Escobar et al.
    Show authors biography
    Hemogramme is a fundamental tool to asses cystic fibrosis (CF) patients, because multiple factors could change its parameters. The aim of this study was to analyze and describe hematologic patterns of CF patients and determinate their association with infection by Pseudomonas aeruginosa and administration of micronutrients. A conventional Hemogramme, sputum culture, medical history and physical examination were performed to 19 CF patients. 7 patients (36.8%) presented anemia, only symptomatic in one patient and mild in all cases. 4 patients (21%) received an inadequate supplementation with micronutrients. It wasn’t a significant association between anemia and micronutrients supplementation regimen with RR 0,63 CI95%(0,18 – 3,81). 4 (21%) presented leucocytosis, in 2 patients (10.5%) we found eosinophilia. We isolated Pseudomonas aeruginosa in 8 patients (42%). Finding a significant association between anemia and infection by Pseudomonas aeruginosa with a un RR of 8,25 CI95%(1,22 – 12,06), not being significant between abnormalities in leucocytes values and Pseudomonas aeruginosa. The prevalence of anemia in our study was higher than what is reported in literature and it’s probably a ferropenic anemia, that is maybe related to infection by Pseudomonas aeruginosa, while administration of micronutrients is possibly not related with that. Lots of factors in CF patients influence levels of leucocytes without having any clinical manifestation. Chronic administration of drugs could be an important factor that could alter hematologic parameters.

    Article visits 150 | PDF visits 79

    Downloads

    Download data is not yet available.
    1. Ratjen F, Döring G. Cystic fibrosis. Lancet. 2003;361:681–689.
    2. Bobadilla J, Macek M, Fine J, Farrell P. Cystic fibrosis: a worldwide analysis of CFTR mutations: correlation with incidence data and application to screening. Hum Mutat. 2002;19:575-606.
    3. Keyeux G, Rodas MC, Bienvenu T, Garavito P, Vidaud, Sanchez D, et al. CFTR mutations in patients from Colombia: Implications for local and regional molecular diagnosis programs. Hum Mutat. 2003;22:259.
    4. Organización Mundial de la Salud (OMS). The molecular genetic epidemiology of cystic fibrosis. Ginebra: WHO; 2004.
    5. Instituto de Genética, Universidad Nacional de Colombia. Fibrosis quística, Fibrosis quística en Colombia. Disponible en: http://www.genetica.unal.edu.co/pages/fibrosis.html. Consultado: 11 de Julio 2008 .
    6. Heijerman H. Infection and inflammation in cystic fibrosis: A short review. J Cyst Fibros. 2005;4:3-5.
    7. Taccetti G, Campana S, Festini F, Mascherini M, Doring G. Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients. Eur Respir J. 2005;26:458–461.
    8. Jiménez TS, Bousoño GC, Ruiz DP. Protocolos de Patología respiratoria. Patología pulmonar en la fibrosis quística. Bol Soc Catalana Pediatr. 2007;47 Suppl 2:S7-13.
    9. Cystic Fibrosis Foundation Patient Registry, 2000. Annual Data Report. Bethesda, Maryland; 2001.
    10. Sánchez I, Perez M, Boza M, Lezana V, Vila M, Repetto G, et al. Consenso nacional de fibrosis quística. Rev Chil Pediatr. 2001;72:356–380.
    11. Girón R, Salcedo A, Casanova A. Antecedentes históricos y epidemiología. En: Girón R, Salcedo A, eds. Monografía de Fibrosis Quística. Madrid: Ergón; 2005. p. 9-20.
    12. Becker A. Interpretación del hemograma. Rev Chil Pediatr. 2001;72:460-465.
    13. García M, Garfia C, Manzanares J. Fibrosis quística. Monografías Neumomadrid. 1ª ed. Madrid: Ergón; 2005.
    14. Organización Mundial de la Salud (OMS). Iron deficiency anaemia: assessment, prevention, and control. A guide for program managers. Guía Tecnica. Ginebra: OMS; 2004. Xiii.
    15. Sinaasappel M, Stern M, Littlewood J, Wolfe S, Steinkamp G, Heijerman H, et al. Nutrition in patients with cystic fibrosis: a European consensus. J Cystic Fibrosis. 2002;1:51-75.
    16. Wilfond B, Farrell P, Laxova A. Severe haemolytic anemia associated with vitamine E deficiency in infants with cystic fibrosis. Clin Pediatr. 1994;33:2–7.
    17. Torres D. Estudio clínico epidemiológico de la fibrosis quística en el Instituto de Salud del Niño, Lima 1991 – 2002. Paediatrica. 2002;4:-15.
    18. Dowsett J, Tully O. Cystic fibrosis. En: Caballero B, Allen L, Prentice A, editores. Encyclopedia of Human Nutrition. 2°ed. Boston: Elsevier/Academic Press; 2005. p 494-501.
    19. Stoltzfus RJ. Iron-deficiency anemia: reexamining the nature and magnitude of the public health problem. Summary: implications for research and programs. J Nutr. 2001;131(2 Suppl 2): 697S-700S.
    20. Kahre T, Teder M, Panov M, Metspalu A. Severe CF manifestation with anaemia and failure to thrive in a 394delTT homozygous patient. J Cyst Fibros. 2004;3:58-60.
    21. Steven M. Rowe M, Miller S. Mechanisms of disease cystic fibrosis. N Engl J Med. 2001;352:1992-2001.
    22. Ramsey B, Accurso F, Cutting G, Welsh M. Cystic fibrosis. In: Valle D, Beaudet A, Vogelstein B, Kenneth K, Antonarakis S, Ballabio A editors. The metabolic and molecular bases of inherited disease. 1ª ed. Baltimore: Mc Graw Hill; 2007. p. 121- 88.
    23. Dodge JA, Turck D. Cystic fibrosis: nutritional consequences and management. Best Pract Res Clin Gastroenterol. 2006;20:531-546.
    24. Lancellotti L, D’Orazio C, Mastella G, Mazzi G, Lippi U. Deficiency of vitamins E and A in cystic fibrosis is independent of pancreatic function and current enzyme and vitamin supplementation. Eur J Pediatr. 1996;155:281-285.
    25. Swann IL, Kendra JR. Anaemia, vitamin E deficiency and failure to thrive in an infant. Clin Lab Haematol. 1998;20:61-63.
    26. Winklhofer-Roob BM. Cystic fibrosis: nutritional status and micronutrients. Curr Opin Clin Nutr Metab Care. 2000;3:293-297.
    27. Rodríguez J, Hernández R, López R. Aproximación al diagnostico de las anemias. BSCP Can Ped. 2001;25:251–255.
    28. Reid DW, Withers NJ, Francis L, Wilson JW, Kotsimbos TC. Iron deficiency in cystic fibrosis: relationship to lung disease severity and chronic Pseudomonas aeruginosa infection. Chest. 2002;121:48-54.
    29. O’connor TM, McGrath DS, Short C, O’donnell MJ, Sheehy M, Bredin CP. Subclinical anaemia of chronic disease in adult patients with cystic fibrosis. J Cyst Fibros. 2002;1:31-34.
    30. Segal E, Grenoville M, Macri C, Fernández A. Consenso de fibrosis quística. Arch argent Pediatr. 1999;97:188–219.
    31. Davies JC. Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistence. Paediatr Respir Rev. 2002;3:128-134.
    32. Gómez MI, Prince A. Opportunistic infections in lung disease: Pseudomonas infections in cystic fibrosis. Curr Opin Pharmacol. 2007;7:244-251.
    33. Wesley A, Dawson K, Hewitt C, Kerr A. Clinical features of individuals with cystic fibrosis in New Zealand. N Z Med J. 1993;106:28-30.
    34. Canadian Cystic Fibrosis Foundation. Canadian patient data registry national report 1998. Toronto: Canadian Cystic Fibrosis Foundation; 2001.
    35. López S, Suarez M. Leucocitosis. Guías clínicas. 2006;6:1–4.
    36. Balke B, Schmoldt S, Häussler S, Suerbaum S, Heesemann J, Hogardt M. A German external quality survey of diagnostic microbiology of respiratory tract infections in patients with cystic fibrosis. J Cyst Fibros. 2008;7:7-14.
    37. Cantón R, Molina A, Máiz L. Fibrosis quística. Monografías Neumomadrid. 2ª ed. Madrid: Ergón; 2005.
    38. Wat D. Impact of respiratory viral infections on cystic fibrosis. Postgrad Med J. 2003;79:201-203.
    39. -------------------------------------------------------------------------------
    40. DOI: http://dx.doi.org/10.22490/24629448.1083
    Tutorials

    Autors:

    How send article?

    Evaluator pair

    How to evaluate an article?

    Information

    Keywords

    Google Scholar profile

    Is part of
     

    Current Issue

    Sistema OJS 3.4.0.5 - Metabiblioteca |